Immunostaining of stromal CD56 cells in ovarian malignancies

OBJECTIVES: The aim of this study was to evaluate CD56 immunostaining in the stroma of benign and malignant ovarian epithelial neoplasms and associate the CD56 immunostaining with prognostic factors and survival in ovarian cancer. METHODS: Patients with ovarian epithelial neoplasia (n=77) were studi...

Descripción completa

Detalles Bibliográficos
Autores principales: de Lima, Cid Almeida, Jammal, Millena Prata, Etchebehere, Renata Margarida, Murta, Eddie Fernando Candido, Nomelini, Rosekeila Simões
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Associação Médica Brasileira 2023
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10185054/
https://www.ncbi.nlm.nih.gov/pubmed/37194901
http://dx.doi.org/10.1590/1806-9282.20220992

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10185054/
https://www.ncbi.nlm.nih.gov/pubmed/37194901
http://dx.doi.org/10.1590/1806-9282.20220992

Ejemplares similares